Showing results (21-30 of 233) with videos related to

Sort By:
Pageof 24
Journal of Fungi (Basel, Switzerland)|January 30, 2018
Invasive Candidiasis in Various Patient Populations: Incorporating Non-Culture Diagnostic Tests into Rational Management StrategiesCornelius J Clancy, Ryan K Shields, M Hong Nguyen
Open Forum Infectious Diseases|November 22, 2021
Invasive Pulmonary Aspergillosis Complicating Noninfluenza Respiratory Viral Infections in Solid Organ Transplant RecipientsAnna Apostolopoulou, Cornelius J Clancy, Abigail Skeel, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2012
Caspofungin kills Candida albicans by causing both cellular apoptosis and necrosisBinghua Hao, Shaoji Cheng, Cornelius J Clancy, et al.
Open Forum Infectious Diseases|March 18, 2021
Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem StudiesCornelius J Clancy, Ilan S Schwartz, Brittany Kula, et al.
Open Forum Infectious Diseases|October 30, 2019
Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription DataCornelius J Clancy, Brian A Potoski, Deanna Buehrle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 30, 2026
Current state of knowledge on medical cannabis use and risk for infections: A practical guide for cliniciansKailey Hughes Kramer, Will Garner, Cornelius J Clancy, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniaeRyan K Shields, Cornelius J Clancy, Ellen G Press, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Five-minute exposure to caspofungin results in prolonged postantifungal effects and eliminates the paradoxical growth of Candida albicansRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Diagnostic Microbiology and Infectious Disease|December 23, 2019
Sequence type-258 carbapenem-resistant Klebsiella pneumoniae isolates in which ceftazidime-avibactam resistance emerged are not hypermutatorsKevin M Squires, M Hong Nguyen, Ryan K Shields, et al.
Clinical Pharmacokinetics|May 21, 2010
Pharmacokinetic/pharmacodynamic profile of posaconazoleYanjun Li, Ursula Theuretzbacher, Cornelius J Clancy, et al.
Pageof 24